Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.apollohospdelhi.com | |
Market Cap | 1,710.62 Cr. | |
Enterprise Value(EV) | 1,503.30 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 11.35 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 16.43 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 63.07 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 45.24 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 4.12 | Calculated using Price: 186.60 |
Dividend Yield | 1.61 | Period Ending 2023-03 |
No. of Shares Subscribed | 9.17 Cr. | 91,673,000 Shares |
FaceValue | 10 | |
About Indraprastha Medical Corporation Ltd. | ||
It offers a range of diagnostic, medical, and surgical facilities for the care of its patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. It also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the company's diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, it offers ambulance and air ambulance services, as well as out patient consultation services. |
1 Day |
|
-1.97% |
1 Week |
|
-11.63% |
1 Month |
|
-1.01% |
3 Month |
|
+11.07% |
6 Month |
|
+108.28% |
1 Year |
|
+127.56% |
2 Year |
|
+134.27% |
5 Year |
|
+379.08% |
10 Year |
|
+425.63% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 17.02 | 11.68 | 11.55 | 9.11 | 11.93 | 17.05 | 0.86 | 19.60 | 24.44 | |
Return on Capital Employed (%) | 23.29 | 17.72 | 16.98 | 14.40 | 18.29 | 20.15 | 2.80 | 27.58 | 34.46 | |
Return on Assets (%) | 7.30 | 5.42 | 5.71 | 4.74 | 6.65 | 10.01 | 0.53 | 13.12 | 16.94 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 195 | 224 | 231 | 232 | 244 | 268 | 273 | 325 | 379 | 415 | |
Non Curr. Liab. | 53 | 46 | 42 | 62 | 54 | 42 | 43 | 43 | 46 | 46 | |
Curr. Liab. | 194 | 191 | 186 | 138 | 124 | 140 | 116 | 94 | 130 | 207 | |
Minority Int. | |||||||||||
Equity & Liab. | 442 | 461 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 668 | |
Non Curr. Assets | 293 | 308 | 301 | 299 | 287 | 308 | 291 | 304 | 332 | 365 | |
Curr. Assets | 149 | 152 | 158 | 133 | 136 | 141 | 141 | 157 | 223 | 302 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 442 | 461 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 668 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,175 | |
Other Income | 1 | 2 | 0 | 1 | 0 | 1 | 1 | 3 | 10 | 15 | |
Total Income | 715 | 758 | 766 | 753 | 789 | 831 | 614 | 891 | 1,109 | 1,190 | |
Total Expenditure | -630 | -676 | -687 | -680 | -707 | -744 | -573 | -774 | -948 | -1,007 | |
PBIDT | 86 | 82 | 79 | 74 | 81 | 87 | 41 | 117 | 161 | 183 | |
Interest | -8 | -7 | -8 | -9 | -7 | -6 | -3 | -3 | -4 | -3 | |
Depreciation | -28 | -35 | -31 | -31 | -30 | -33 | -33 | -35 | -39 | -40 | |
Taxation | -17 | -14 | -15 | -13 | -16 | -5 | -2 | -20 | -31 | -36 | |
Exceptional Items | |||||||||||
PAT | 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 104 | |
Adjusted EPS | 4 | 3 | 3 | 2 | 3 | 5 | 0 | 6 | 9 | 11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 58 | 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | |
Cash Fr. Inv. | -22 | -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | |
Cash Fr. Finan. | -36 | -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | |
Net Change | 0 | 0 | 0 | 0 | 1 | 14 | 4 | 5 | 17 | 11 | |
Cash & Cash Eqvt | 2 | 2 | 2 | 2 | 3 | 17 | 20 | 25 | 42 | 52 |
Tue, 05 Dec 2023
Clarification/ Confirmation On News Item Appearing In "Media/Publication" this is with reference to certain allegations made in the UKs Telegraph Newspaper and subsequent coverage in "Times of India" on 5th December 2023 on alleged Mal Practices with regards to the Kidney Transplant Program @ Indraprastha Medical Corporation Limited. In this connection it is reiterated that IMCL considers compliance with all Laws Including the TOHO act as sacrosanct our detailed clarification on the aforesaid news item is as per annexure A. |
Sat, 02 Dec 2023
Announcement under Regulation 30 (LODR)-Change in Directorate This is to inform you that the Company has received a letter from Govt. of NCT Delhi (Promoter of the company) intimating about withdrawal of Nomination Of Mr. Jasmine Shah ( Din 08621290) from the board of directors of the company and accordingly Mr. Jasmine Shah has ceased to be the Non Executive Director and Chairman of the Company. |
Tue, 07 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate This is to inform that the Company has issued duplicate share Certificate in respect of Share Certificates reported to be lost by the shareholder. Details of said Share Certificate are enclosed. |
Fri, 08 Dec 2023 |
|
|
|
|
|